Valid Patents May Undercut Suit Alleging Bausch Health Used Fraudulent Patents to Raise Price
In an FCA case against Bausch Health for allegedly obtaining a fraudulent patent to preserve its monopoly on its colitis drug Apriso, the judge asked the plaintiff's attorney whether other valid patents also protected the drug, commenting that this would invalidate the FCA claim.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.